LUCAS TERRY: Open Payments
NPI 1063105294 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,709 in 94 payments from 13 companies in 2025. Trend: 2023 $861 · 2024 $1,856 · 2025 $1,709
Food & beverage: $1,600Education: $109
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 16 | $285 |
| Janssen Biotech, Inc. | 8 | $284 |
| ABBVIE INC. | 22 | $266 |
| Novartis Pharmaceuticals Corporation | 21 | $247 |
| GENZYME CORPORATION | 9 | $245 |
| Regeneron Healthcare Solutions, Inc. | 1 | $99 |
| PFIZER INC. | 4 | $66 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $48 |
| Incyte Corporation | 2 | $47 |
| Galderma Laboratories, L.P. | 2 | $42 |
Products named: DUPIXENT, Bimzelx, TREMFYA, COSENTYX, SKYRIZI, RINVOQ, CIBINQO, Rhapsido.
Industry payments across NY — which companies pay providers there.
